WinstonWınston
Maximus logo

Maximus

MMS
47
Specialty Business Services · Industrials
Price
$58.30
-0.73 (-1.24%)
Market Cap
$3.06B
Winston Score
47
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Share count falling — buybacks

7.1% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 62.4M (2021) → 57.9M (2025)

Maximus helps governments run large social programs. The company manages services like Medicaid enrollment, welfare-to-work programs, student loan servicing, and health insurance marketplaces on behalf of federal, state, and local governments in the United States, United Kingdom, Australia, and Canada. It is one of the largest private contractors in the world focused specifically on government health and human services programs.

Maximus earns money through long-term government contracts, typically paid on a fee-for-service or cost-plus basis. Most revenue comes from the U.S. federal and state governments, making the company heavily dependent on public sector budgets and contract renewals. Its main competitive advantage is deep experience navigating complex government procurement processes, which creates high switching costs once a contract is won. The key risk is that government budget cuts, policy changes, or contract losses — particularly around Medicaid, which drove significant revenue during the COVID-era public health unwinding — could meaningfully reduce future earnings.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
23.6%
Thin — 23.6% gross margin
Operating Margin
9.4%
Modest — 9.4% operating margin
ROCE
4.1%
Weak — 4.1% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-0.2%
Shrinking sales (-0.2% YoY)
EPS YoY
+41.8%
Earnings growing fast (41.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
71%
Modest — 71% of profit becomes cash
FCF Margin
4.1%
Thin free cash flow (4.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.82
Moderate — manageable debt (0.82)
Interest Cover
6.76x
Adequate interest coverage (6.8x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
8.8x
Attractive valuation — P/E 8.8

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
+2.1
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.22%
Moderate income — 2.22% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+7.5%
Dividend growing modestly (7.5% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial